Abstract

Second Generation Proteasome Inhibitor is More Potent than Doxorubicin (Firstline Drug) in Inhibiting Proliferation and Inducing Apoptosis in Human Triplenegative Breast MDAMB231 Cancer Cells

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call